EUR 17.76 For Business Accounts Only

ValuEngine Rating and Forecast Report for ACST

ValuEngine Rating and Forecast Report for ACST
Acasti Pharma

Acasti Pharma is a biopharmaceutical company based in Canada. Co. is engaged in the research, development and commercialization of new therapies for abnormalities in blood lipids, referred to as dyslipidemia, and the treatment and prevention of cardiovascular disorders. Co.'s products are derived from krill oil. Co.'s products include: CaPre® is for prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia; and Onemia™ is for cardiometabolic disorders treatments. Co. sells its products primarily in Canada and the U.S.

ValuEngine Inc
ValuEngine Inc

​ValuEngine Rating and Forecast Reports provide the most comprehensive and useful report available. ValuEngine's three models: Valuation Model, Forecast Model and Ratings Model are incorporated to give you a well-rounded analysis from three different perspectives. ValuEngine provides coverage of over 5300 US stocks (which includes over 800 ADRs), all of which are updated daily after US market close.


ResearchPool Subscriptions

Get the most out of your insights

Get in touch